biotech-therapeutics

Kyverna Therapeutics (Nasdaq: KYTX) is a patient-centered, clinical-stage biopharmaceutical company headquartered in Emeryville, California, developing engineered T cell therapies for patients suffering from autoimmune diseases.

Gameto is a female-led clinical-stage biotechnology company redefining women's health across the reproductive lifespan. Using proprietary induced pluripotent stem cell (iPSC) engineering, Gameto develops ovarian cell lines that mimic the biology of the female reproductive system.

ArrePath is an AI-driven pharmaceutical company based in Princeton, New Jersey, applying machine learning to accelerate small-molecule drug discovery in infectious disease. Its platform treats heterogeneous, small, and noisy bioactivity datasets as a modeling opportunity, enabling work on novel chemical classes where conventional approaches…

Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics to restore mitochondrial quality control in age- and disease-related conditions. Its platform advances small molecules, peptides, and nanoparticles that enhance identification and clearance of dysfunctional mitochondria.

Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots.

DEM BioPharma is a Cambridge, Massachusetts biotechnology company developing first-in-class cancer therapeutics that target the signals solid tumors use to evade immune destruction. The company pioneers next-generation macrophage and innate-immune immunotherapies discovered through its proprietary CHoMP (Co-culture with Human Myeloid Phagocytes)…

Averna Therapeutics is a genetic-medicine biotechnology company creating what it calls the last, great missing tool required to break through the most persistent barriers in genetic medicine. Backed by Insight Partners, the company was recognized as an Endpoints 11 Most Promising Biotech Company in 2025 and has presented at the 44th Annual J.P.

Superluminal Medicines is a drug discovery company that combines structure-based drug discovery with AI-powered computational methods and experimental validation to identify and develop small molecule therapeutics.

Chemify Limited is a chemistry-automation company founded in 2022 by Professor Lee Cronin, building on two decades of research at the University of Glasgow and headquartered in Glasgow, Scotland.

NanoMosaic is a biotechnology company delivering ultra-sensitive multiomics powered by its NanoNeedle single-molecule detection technology, purpose-built for gene therapy analytics, neurology biomarkers, and brain health research.

Cirsium Biosciences is a biotechnology company democratizing gene therapy through transformative manufacturing methods. It develops viral vector production systems that use whole plants as bioreactors, offering a highly scalable, linear scale-out platform for producing recombinant AAV (adeno-associated virus) vectors.